House Ethics Committee under pressure to release report on misconduct allegations against former Rep. Matt Gaetz, with political implications for his potential confirmation as attorney general.
Novartis raises mid-term sales guidance, citing strong drug performance and promising pipeline, but analysts express concerns about sustaining growth beyond 2029.
House Ethics Committee under pressure to release report on misconduct allegations against former Rep. Matt Gaetz, with political implications for his potential confirmation as attorney general.
Novartis raises mid-term sales guidance, citing strong drug performance and promising pipeline, but analysts express concerns about sustaining growth beyond 2029.